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Abstract
HIV-1 Rev plays an important role in the late phase of HIV-1 replication, which facilitates export of unspliced viral mRNAs
from the nucleus to cytoplasm in infected cells. Recent studies have shown that DDX1 and DDX3 are co-factors of Rev for
the export of HIV-1 transcripts. In this report, we have demonstrated that DDX5 (p68), which is a multifunctional DEAD-box
RNA helicase, functions as a new cellular co-factor of HIV-1 Rev. We found that DDX5 affects Rev function through the Rev-
RRE axis and subsequently enhances HIV-1 replication. Confocal microscopy and co-immunoprecipitation analysis indicated
that DDX5 binds to Rev and this interaction is largely dependent on RNA. If the DEAD-box motif of DDX5 is mutated, DDX5
loses almost all of its ability to bind to Rev, indicating that the DEAD-box motif of DDX5 is required for the interaction
between DDX5 and Rev. Our data indicate that interference of DDX5-Rev interaction could reduce HIV-1 replication and
potentially provide a new molecular target for anti-HIV-1 therapeutics.
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Introduction
The Rev protein of human immunodeficiency virus type 1
(HIV-1) is a 19 kDa protein produced from fully spliced mRNA in
the early phase of HIV-1 gene expression, and functions as a
nucleocytoplasmic shuttling phosphoprotein [1]. Rev is a key
regulator of HIV-1 replication because it enables the transition
from the early phase of gene expression to the late phase [2,3].
Binding to unspliced and incompletely spliced HIV-1 transcripts
and shuttling of these mRNAs from the nucleus to cytoplasm are
the best-characterized function of Rev [4]. The efficient export of
nuclear/cytoplasmic RNA is accomplished by binding to the Rev
Response Element (RRE) within these mRNAs [5]. The RRE
sequence spans approximately 350 nucleotides (nt), is located
within the env region of unspliced or incompletely spliced mRNAs,
and is absent in completely spliced mRNAs [6,7]. In addition to
the export of unspliced or incompletely spliced mRNA, Rev also
enhances their translation and increases the half-life of RRE-
containing mRNAs in the nucleus [3].
Many Rev co-factors have been identified, including CRM1
(chromosome maintenance region 1) and several members of the
DEAD-box RNA helicase family [8,9,10]. The DEAD-box
protein family is a group of RNA helicases that play roles in
many biological processes such as transcription, pre-mRNA
splicing and export, ribosomal biogenesis, translational initiation,
and RNA decay [11,12,13]. The motif for which these proteins are
named contains the highly conserved Asp-Glu-Ala-Asp amino acid
sequence, which is known as the DEAD-box. This motif (described
as motif II), together with motif I, Q-motif, and motif VI, is
required for ATP binding and hydrolysis. In addition, DEAD-box
helicases carry out their functions with some co-factors that
increase helicase specificity and enzymatic activity [14,15,16].
In recent years, genome-wide screening technologies have been
used by several groups to clarify cellular factors that affect HIV-1
replication. More than 300 cellular factors have been identified as
a result of these studies [5,17,18,19,20,21,22]. Among these
factors, several are members of the DEAD-box helicase family
including DDX5 (P68) [18]. DDX5 is a multifunctional DEAD-
box RNA helicase. It functions as an enzyme that unwinds double-
stranded RNA and is a nucleocytoplasmic shuttling protein whose
action is mediated by a Ran GTPase-dependent pathway [23,24].
Previously studies identified DDX1 and DDX3 as co-factors of
Rev in the export of unspliced and partially spliced HIV-1
mRNAs from the nucleus to cytoplasm [9,10]. Like its counter-
parts, DDX5 may also be involved in the Rev/RRE-dependent
pathway of HIV-1. Through various approaches, we herein
demonstrated that DDX5 functions as a new co-factor of HIV-1
Rev and that it enhances the transport of HIV-1 transcripts.
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Materials and Methods
Ethics Statement
This research was approved by the Ethics Review Board of Sun
Yat-Sen University. The written informed consent was provided
by study participants and/or their legal guardians.
Plasmids
Human DDX5 with an HA or FLAG epitope tag sequence at its
39 terminus was amplified through reverse transcription-polymer-
ase chain reaction (RT-PCR) with the mRNA of human
peripheral blood mononuclear cells (PBMCs) as template.
Accuracy was confirmed by DNA sequencing. The tagged
DDX5 was then inserted into a pcDNA3.1 vector. pcDNA3.1-
Rev, expressing HIV-1 Rev, was constructed as previously
described [25]. The gfp and HIV-1 rev with HA tag sequences at
their C-termini were amplified from pEGFP-C1 (Clontech) or
pcDNA3.1-Rev via PCR, and the accuracy was confirmed by
DNA sequencing. The tagged gfp or rev was then inserted into a
pcDNA3.1 vector. HIV-1 rev and human DDX5 were PCR
amplified from pcDNA3.1-Rev or pcDNA3.1-DDX5-HA, and
then rev was inserted into pEGFP-N1 (Clontech) to generate
pEGFP-N1-Rev, respectively. The DDX5-DEAD-box mutant
plasmid pcDNA3.1-DDX5 mutant-FLAG and pcDNA3.1-
DDX5 mutant-HA were constructed via PCR-based mutagenesis
from pcDNA3.1-DDX5-FLAG or pcDNA3.1-DDX5-HA by
replacing the DEAD-box motif with 4 alanine amino acids.
pDM628, a Rev/RRE-dependent reporter vector, was construct-
ed as previously described [9,26]. pRL-TK, which expresses renilla
luciferase, was obtained from Promega as a transfection normal-
ization reporter. pNL4-3 contains a full infectious clone of HIV-1
provirus [27]. HIV-1 provirus pNL4-3-DEnv-GFP was construct-
ed by Dr. Siliciano9s lab and obtained from AIDS Reference
Reagent Program of NIH [28]. The HIV-1-based second
generation packaging vector pCMVDR8.2 (lacking only the env
gene) was directly obtained from Dr. Trono9s lab [29]. pMDLg/
RRE is a third generation lentiviral packaging plasmid that
contains HIV-1 gag and pol genes as well as the element encoding
HIV-1 RRE, and was obtained from Dr. Trono9s lab via
Addgene. To replace the RRE sequence with a Constitutive
Transport Element (CTE) of the type D Mason-Pfizer monkey
virus (MPMV), two rounds of PCR amplification were performed
as follows. In the first round of PCR, three fragments were
amplified. The 191-bp CTE-containing fragment was derived
from pDM128/CTE (CTE-up: 5’-ATTCCGGAGCGGCCG-
CAAGACTGGACAGCCAATGACGGGTA; CTE-dn: 5’-CCA-
GAGCAACCCCAAATCCCCCACATCCCTCG-
GAGGCTGCGCCTG-3’) [8]. A 393-bp fragment was PCR
amplified from pMDLg/RRE using primers 393-up: 5’-
CCGCTTAAGACAGCAGTACAAATGGCAGT-3’ (the AflII
site is underlined) and 393-dn: 5’-
TGGCTGTCCAGTCTTGCGGCCGCTCCGGAATTC-
CATGTGT-3’. The third fragment (166 bp) was also derived
from pMDLg/RRE via PCR (166-up: 5’-GCCTCCGAGG-
GATGTGGGGGATTTGGGGTTGCTCTGGA-3’; 166-dn:
5’-TCCCCGCGGAAGCTTGTGTAATTGTTA, the SacII site
is underlined). In the second round of PCR, the three PCR
products above were mixed in an equimolar ratio and amplified
with 393-up primer and 166-dn primer. The 682-bp AflII-SacII-
flanked fragment, containing the CTE sequence, was digested with
AflII and SacII, and cloned into the pMDLg/RRE vector that was
digested with the identical enzymes so as to construct the
recombinant plasmid pMDLg/CTE.
Cells and Transfection
TZM-bl cells, which harbor an HIV-1 promoter-driven
luciferease gene, were obtained from AIDS Reference Reagent
Program, NIH. Human 293T, HeLa, and TZM-bl cells were
maintained in Dulbecco9s modified Eagle9s medium (DMEM)
(Hyclone) supplemented with 10% fetal bovine serum (FBS)
(Invitrogen), 100 units/ml of penicillin and 100 mg/ml of
streptomycin at 37uC. The 293T, HeLa, and TZM-bl cells were
transfected using Lipofectamine 2000 (Invitrogen) for plasmids
and siRNAs. The procedures recommended by the manufacturer
were followed. The cells were collected at 48 h post-transfection
(p.t.) for reporter and protein expression assays.
siRNA Synthesis
Small interfering RNAs (siRNAs) for human DDX5 and gfp were
purchased from Dharmacon. The target sequence in human
DDX5 for siRNA was 59-CCGCAACCAUUGACGCCAUTT-39
[30]. The target sequence in gfp for siRNA was 59-ACG-
TAAACGGCCACAAGTTC-39. siRNA for gfp was used as a
negative control.
Luciferase Assay
The luciferase assay was performed as described previously
[31,32].
Purification and Activation of Human Primary CD4+T
Cells
Peripheral blood mononuclear cells (PBMCs) were isolated from
normal human donors through Ficoll gradient centrifugation,
followed by culturing in conditioned RPMI 1640 medium. Human
primary CD4+T cells were then purified with human CD4+T cell
isolation kit according to the manufacturer’s instructions (Miltenyi
Biotec).
Human primary CD4+T cells were stimulated with phytohe-
magglutinin (PHA, 5 ng/ml) and interleukin-2 (IL-2, 10 ng/ml)
for 48 h, and then, cells were washed three times with phosphate-
buffered saline (PBS) buffer, and cultured in the presence of IL-2
(10 ng/ml). Every three days, the culture was added with half
volume of fresh conditioned RPMI 1640 medium containing IL-2
(10 ng/ml).
Production of HIV-1
293T cells were transfected with 10 mg of pNL4-3 by using
Lipofectamine 2000 (Invitrogen) according to manufacturer’s
instructions. Cells supernatants were harvested at 48 h post-
transfection (p.t.) and stored at 280uC.
p24 ELISA Assay for Plasmids Transfection and HIV-1
Infection
293T cells were seeded in 24-well plates (0.56105 cells/well)
and transfected with target plasmids. Viral supernatants were
collected at 48 h p.t.
To normalize viral inputs, the amount of p24 was measured by
HIV-1 p24 ELISA kit according to manufacturer’s instructions
(Clonetech). Human primary activated CD4+T cells were seeded
into 24-well cell culture plates (16106 cells/well) and infected with
the equivalent of 5 ng HIV-1 p24 antigen in 1 ml for 3 h at 37uC.
And then, supernatants were removed and cells were washed three
times with fresh PBS buffer. The cells were maintained in
conditioned RPMI 1640 medium supplemented with IL-2 (10 ng/
ml) and transfected with 30 nmol DDX5-siRNA (GFP-siRNA as a
control) every 2 days by using RNAiMAX (Invitrogen). Viral
supernatants were harvested after 5 days post-infection.
DDX5 Functions as a Co-Factor of Rev
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All of the viral supernatants were detected using a HIV-1 p24
ELISA kit according to the manufacturer’s instructions (Clone-
tech).
Preparation of HIV-1 p24 Antibody
HIV-1 p24 expression frame, which was amplified from pNL4-3
via PCR, was inserted into pET28a, a prokaryotic expression
vector (Novagen). Then, HIV-1 p24 was expressed in E. coli with a
His-tag at the 59-terminus. The protein was then purified through
the immobilized metal ion affinity chromatography (IMAC). The
purity of isolated recombinant protein was approximately 95%, as
measured by Coomassie brilliant blue staining. Two NZW SPF
rabbits (New Zealand white rabbits that are specific pathogen-free)
were used for immunization. The subcutaneous injections were
completed as the emulsions mixed with complete Freund’s
adjuvant (CFA) or incomplete Freund’s adjuvant (IFA). After
immunonization four times, cardiac blood samples were collected.
The IgG was isolated from the rabbit serum through protein A
(GeneScript L00210) affinity purification. The efficacy of the
antibody was measured by ELISA and Western blotting.
Co-immunoprecipitation and Western Blotting
In preparation for transfection, 1.56106 HeLa cells were plated
onto 60-millimeter (mm)-diameter cell culture plate and grown at
37uC in 5 ml Dulbecco’s modified Eagle’s medium (DMEM). The
cells were then transfected with 6 mg pcDNA3.1-DDX5-HA or
pcDNA3.1-GFP-HA. After 24 h, cells were collected and treated
with lysis buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.5), and
1mM EDTA, 1% Triton X-100, and 0.5% NP-40]. Co-
immunoprecipitation and Western blotting were then performed
as previously described [32]. The anti-HA antibody (mouse
monoclonal, Covance), anti-b-actin antibody (rabbit polyclonal,
CST), and anti-p24 antibody were used as primary antibodies.
Quantity One (Biorad) was used to quantify the Western blotting
results.
Immunofluorescence and Confocal Imaging
HeLa cells were seeded onto 35-mm glass-bottom culture dishes
(MatTek) and then co-transfected with 200 ng pEGFP-N1-Rev
and 800 ng pcDNA3.1-DDX5-HA (or pcDNA3.1-DDX5-mu-
tant-HA). At 36 h p.t., the dishes were washed with PBS buffer
and the cells were fixed with 4% paraformaldehyde for 10 min at
room temperature (RT). The dishes were then washed by PBS
buffer for three times and were immersed in 0.2% Triton X-100
solution for 10 min at RT, followed by washing with PBS buffer
for three times. The dishes were treated with 5% BSA blocking
solution for 30 min and then washed by PBS buffer for two times.
The anti-HA antibody solution was added for 1 h at RT and then
washed by PBST buffer for three times. The secondary antibody
(Goat anti-mouse IgG, purchased from Abcam) was subsequently
added and incubated for 45 min at RT, followed by washing for
four times. DAPI solution (0.5 mg/ml) was then added and
subsequently washed by PBS buffer for three times. The cells on
the dishes were examined with a Leica laser-scanning fluorescence
microscope. All images were digitally recorded and merged using
the Leica software. The magnification used to collect images was
600.
Real-time RT-PCR
Primers firefly luciferase-F (59-TGGGCGCGTTATT-
TATCGGA-39) and firefly luciferase-R (59-CACTACGG-
TAGGCTGCGAAA-39) were synthesized for detection of the
firefly luciferase gene in pDM628. Primers renilla luciferase-F (59-
GCCAGTAGCGCGGTGTATTA-39) and renilla luciferase-R (59-
AAATGCCAAACAAGCACCCC-39) were synthesized for detec-
tion of the renilla luciferase gene in pRL-TK. Two pairs of RT-PCR
primers, 628-F (59-GAAGAAGCGGAGACAGCGACGAA-
GAGCTC-39)/628-dn-RT (59-CCAGCGGTTCCATCCTCTA-
GAGGATAGA-39) and 628-F/628-Sp-RT (59-
CTAAAGCTGCCTTGTAAGTCATTGGTC-39) were synthe-
sized by Invitrogen to detect unspliced and spliced mRNAs
generated from pDM628. Primers gag-pol-F and gag-pol-R were
used for detection of gag-pol mRNA (gag-pol-F, 59-CGATAGA-
CAAGGAACTGTA-39; gag-pol-R, 59-TGACAGGTG-
TAGGTCCTACT-39). Primers gag-F (59-TGGCTTCTTATGC-
GACGGATCG-39) and gag-R (59-
CTCCCTGCTTGCCCATACTA-39) were synthesized for de-
tection of the gag gene. Primers tat-F and tat-R were used for
detection of the tat gene (tat-F, 59-GAGCCAGTAGATCCTA-
GACTAGA-39; tat-R, 59-CCCTCGGGATTGGGAGGTG-39).
Primers rev-F and rev-R were used for detection of the rev gene
(rev-F, 59-AGACTCATCAAGCTTCTCTATC-39; rev-R, 59-
TTCCACAATCCTCGTTACAATC-39). Fractionation of cyto-
plasmic and nuclear components and RNA extraction were
performed according to the manufacturer’s instructions (PARIS,
Ambion). Reverse transcription reactions were performed with
PrimeScript RT reagent Kit (TaKaRa). Real-time PCR proce-
dures recommended by the manufacturer were followed (SYBR
Premix ExTaq, TaKaRa) on a CFX96 Real-Time System (Bio-
Rad). Human GAPDH and/or b-actin mRNA was measured as
an endogenous control.
Results
Importance of DDX5 for HIV-1 Replication
Recently, Bushman et al analyzed the full panel of HIV-1
infection-associated proteins [18]. Among these proteins, DDX5 is
involved in Rev-associated complex, indicating its specific links to
HIV-1 replication [18]. Previous studies have found that some
DEAD-box RNA helicases, such as DDX1, DDX3, DDX10,
DDX53 and DDX55, are required for HIV-1 replication
[9,10,17]. As DDX5 also belongs to the DEAD-box RNA helicase
family, we hypothesized that DDX5 could function as a co-factor
in HIV-1 replication. To this end, we transfected 293T cells with
the HIV-1 molecular clone pNL4-3DEnv-GFP and the DDX5-
HA-expressing plasmid. The transfected cells could then be
monitored by the fluorescence of GFP. Compared to negative
control, a significant difference was observed in DDX5-expressing
cells at 48 h post-transfection (p.t.) (Fig. 1A). To further confirm
this finding, a dose-dependent experiment was performed. Firstly,
we transfected 293T cells with differing amounts of pcDNA3.1-
DDX5-HA and detected the expression of DDX5 in cells by
Western blotting. Then, the 293T cells were transfected with
pNL4-3DEnv-GFP and differing amounts of DDX5-HA-express-
ing plasmids. Forty-eight hours later, p24 expression of cell culture
supernatants was analyzed. Compared to the vector control,
DDX5 enhanced the production of HIV-1 p24 significantly and
this increase correlated with the expression level of DDX5
(Fig. 1C). The same phenotype was recapitulated with two other
types of HIV-1 molecular clones (pCMVDR8.2 and pNL4-3;
Fig. 1D and E). During DDX5 overexpression, the 0 ng DDX5
transfection lanes in Fig. 1C–E reveal basal levels of p24 due to the
expression of endogenous DDX5. To better define the effect of
DDX5 on HIV-1 replication, a DDX5-knockdown experiment
was performed. Human primary CD4+T cells were infected with
HIV-1NL4-3 viruses in the presence of DDX5-siRNA. Five days
later, HIV-1 p24 expression of cell culture supernatants was
DDX5 Functions as a Co-Factor of Rev
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analyzed. After depletion of endogenous DDX5, p24 production
from wild-type HIV-1NL4-3 infection was reduced by 30% (Fig. 1F,
top panel) and the p24 production of another type of HIV-1 clone
(pNL4-3DEnv-GFP) was decreased by ,72% (Fig. S1A, top
panel). The depression effect of DDX5 knockdown on p24
production in the presence of wild-type HIV-1 infection (Fig. 1F,
top panel) is only 30%, which could be due to input of wild-type
HIV-1 is relatively high and the knockdown efficiency of DDX5
by exogenous siRNA in primary human CD4+T cells is not good
(only ,27% decrease) (Fig. 1F, bottom panel). The same
phenotype was recapitulated with another type of HIV-1
molecular clone (pNL4-3DEnv-GFP; Fig. S1A). Since several
DEAD-box proteins (such as DDX1 and DDX3) are already
known to be Rev co-factors, a substitution experiment was
performed to detect the particular importance of DDX5. DDX1
or DDX3 overexpression after DDX5 knockdown only partially
recued the function of DDX5 (Fig. S1B). All these results indicated
that DDX5 is required for HIV-1 replication in human cells and
has its particular importance to HIV-1 replication.
DDX5 is Required for the Efficient Function of HIV-1 Rev
Previous studies showed that RNA helicase acted either
transcriptionally or post-transcriptionally [33,34]. As a member
of the RNA helicase family, DDX5 might affect either Tat or Rev
function. To clarify these possibilities, TZM-bl cells were co-
transfected with a DDX5-expressing plasmid (or DDX5-specific
siRNA) and HIV-1 Tat proteins. Neither DDX5-overexpression
nor DDX5-knockdown affected the expression of the LTR
luciferase reporter gene in TZM-bl cells (data not shown),
indicating that DDX5 does not affect the function of Tat.
Next, the Rev-responsive RRE-containing pDM628 plasmid
was used to detect the effect of DDX5 on post-transcriptional gene
regulation (Fig. 2A) [35]. The effects of DDX5 on firefly luciferase
gene (expressed by pDM628) and renilla luciferase gene (expressed
by pRL-TK, the transfection reporter) were detected. Fig. S2
showed that DDX5 did not influence the transcription from each
reporter plasmids. DDX5 also did not affect the basal expression
of pDM628 (15 ng) when DDX5 (60 ng) was expressed in 293T
cells (Fig. 2B, lane1). However, when DDX5 (60 ng) was co-
expressed with Rev (15 ng), the expression of the Rev-dependent
reporter increased by ,7-fold (Fig. 2B, lane 2). To further confirm
this phenotype, a DDX5-dose-dependent experiment was per-
formed. The enhancing effect of DDX5 on the reporter in
pDM628 was found to correlate with the level of DDX5
expression (Fig. 2C). The 0 ng DDX5 transfection lane (lane 1
in Fig. 2C) still allows pDM628 expression possibly because of the
expression of endogenous DDX5. After depletion of endogenous
DDX5, we also recapitulated the similar phenotype (Fig. 2D).
Collectively, these data suggested that DDX5 is important for the
efficient function of HIV-1 Rev.
DDX5 Regulates Rev/RRE- but not CTE-dependent
Reporter Gene Expression
As Rev is required for the export of HIV-1 Gag-encoding
mRNA from the nucleus to cytoplasm by binding with an RRE
sequence, the above results imply a role for DDX5 in an Rev/
RRE-dependent shuttling function [3,4,6,25]. To address this
issue, pMDLg/RRE and pMDLg/CTE reporter plasmids were
used to examine the effect of DDX5 on Rev/RRE-dependent
export. Both of pMDLg/RRE and pMDLg/CTE are the CMV-
driven Gag/Pol vectors. The pMDLg/RRE vector (Fig. 3A,
bottom panel) contains the RRE element and expresses Gag
protein in a Rev-dependent manner, whereas pMDLg/CTE
(Fig. 3A, top panel) contains a MPMV constitutive transport
element (CTE) and expresses protein in a Rev-independent
manner [7]. Rev/RRE-dependent expression of p24 and p55
Gag was enhanced significantly by co-expression of DDX5
(Fig. 3B, left). However, when we repeated the above experiment
with a Rev/RRE-independent pMDLg/CTE vector, the expres-
sion of p24 and p55 Gag was not affected by DDX5 co-expression
(Fig. 3B, right). The same experiments were also performed in the
presence of DDX5-siRNA (Fig. 3C) and consistent with the above
results. Given that CTE-mediated expression of Gag was
independent of Rev, pMDLg/CTE reveals traces of transport
and p24 expression (Fig. 3B and C, right, bottom panel). All these
results demonstrated that DDX5 functions specifically in Rev/
RRE-dependent reporter gene expression.
DDX5 Enhanced the Export of Rev/RRE-dependent
mRNAs
Since DDX5 functions as a co-factor of Rev and enhances the
expression of the Rev-dependent reporter gene (Fig. 2 and Fig. 3),
we then further exclude the possibility that this effect is not on
transcription or splicing. We therefore co-transfected 293T cells
with the HIV-1 molecular clones pNL4-DEnv-GFP and
pcDNA3.1-DDX5-HA and analyzed HIV-1 RNAs by real time-
PCR. HIV-1 mRNAs are divided into three size classes (Fig. 4A,
top panel): The 9-kb unspliced RNA encodes Gag and Gag-Pol
proteins; The 4-kb singly spliced mRNAs encode Vif, Vpu, Vpr,
and Env; The 2-kb fully spliced mRNAs encode Tat, Rev, and
Nef. The primer-binding sites for unspliced HIV-1 mRNAs were
selected in the ORF (Open Reading Frame) of the gag gene, and
the primer-binding sites for the fully spliced mRNAs were selected
in the overlapping coding region of the tat and rev genes.
Comparing the DDX5-expressing sample to controls, we observed
no differences in the expression of total HIV-1 RNAs and spliced
HIV-1 RNAs (Tat or Rev) (Fig. 4A, bottom panel). The same
phenotype was recapitulated after DDX5 knockdown (Fig. S3).
These results suggested that DDX5 cannot affect HIV-1 RNA
transcription or splicing.
Next, we detected cytoplasmic or nuclear distribution of Rev-
dependent pDM628 mRNA by DDX5 co-expression, and found
that DDX5 co-expression exerted no significant effect on whole-
cell pDM628 mRNA (data not shown). However, the cytoplasmic
distribution of pDM628 mRNA increased significantly, indicating
that DDX5 facilitates the export of Rev-dependent reporter
mRNA from the nucleus to cytoplasm (Fig. 4B). As described
above, we have shown that DDX5 regulates Rev/RRE-dependent
but not CTE-dependent reporter gene expression. To determine
whether DDX5 functions specifically in the export of Rev/RRE-
dependent reporter gene mRNA, we performed the identical
experiment with pMDLg/RRE (Fig. 4C) or pMDLg/CTE
(Fig. 4D). Neither the whole-cell Gag-Pol RNA of pMDLg/
RRE nor pMDLg/CTE was affected by DDX5 co-expression
(Fig. 4C, right panel; Fig. 4D, right panel). Moreover, DDX5 did
not affect the cytoplasmic distribution of Gag-Pol mRNA from
pMDLg/CTE (Fig. 4D, left panel). However, the cytoplasmic
distribution of Rev/RRE-dependent Gag-Pol mRNA was en-
hanced ,13-fold by co-expression of DDX5 (Fig. 4C, left panel).
After knockdown of endogenous DDX5, the cytoplasmic distri-
bution of Gag-Pol mRNA from pMDLg/RRE reduced ,60%
(Fig. 4E, left panel) and the export of HIV-1 mRNA, which
generated from pMDLg/CTE, did not change (Fig. 4F). These
data suggested that DDX5 specifically facilitates the export of
Rev/RRE-dependent reporter mRNA from the nucleus to
cytoplasm.
DDX5 Functions as a Co-Factor of Rev
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DDX5 Interacts with Rev in an RNA-dependent Way
As described above, DDX5 functions as a co-factor of Rev in
HIV-1 replication. To further study the mechanism, the subcel-
lular localization of DDX5 and Rev was first examined. For this
purpose, 200 ng pEGFP-N1-Rev and 800 ng pcDNA3.1-DDX5-
HA were co-transfected into HeLa cells. Cells were treated with
immunofluorescence method and then examined with a confocal
laser scanning microscope. The subcellular localization of Rev-
GFP diffused throughout the cytoplasm and nucleus at 36 h p.t.
(Fig. 5A). However, the localization of DDX5-HA was observed to
congregate in the nucleus in transfected cells, which is consistent
with a previous report (Fig. 5A) [24]. Thus, this result showed
partially co-localization of Rev and DDX5, indicating that DDX5
binds to Rev in the nucleus.
To further study the interaction between DDX5 and Rev, HeLa
cells were transfected with a Rev-HA- (6 mg) or GFP-HA-
expressing plasmid (6 mg). After immunoprecipitation with anti-
HA antibody, the immunoprecipitated samples were analyzed
Figure 1. DDX5 is important for HIV-1 replication. A. Fluorescence images show 293T cells co-transfected with pNL4-3DEnv-GFP and
pcDNA3.1-DDX5-HA (or pcDNA3.1) at 48 h p.t. B. Western blotting analysis of DDX5 expression in 293T cells. C, D and E. HIV-1 p24 ELISA assay of
293T cells supernatants. 293T cells in 24-well plates were co-transfected with pNL4-3DEnv-GFP (or pCMVDR8.2, pNL4-3) and differing amounts of
pcDNA3.1-DDX5-HA (pcDNA3.1 as a control). The supernatants were collected at 48 h p.t. for assay of p24 ELISA. F. The effect of DDX5 knockdown on
HIV-1 p24 production. Top, the supernatants from human primary CD4+T cells infected with pNL4-3 in the presence of DDX5-siRNA (GFP-siRNA as a
control) were collected at 5 days post-infection and analyzed with p24 ELISA kit. Bottom, the effect of DDX5-siRNA in human primary CD4+T cells was
detected by Western blotting. Data in C, D, E and F represent mean 6S.D. (error bars).
doi:10.1371/journal.pone.0065040.g001
Figure 2. DDX5 significantly enhances the expression of a Rev-dependent reporter gene. A. Schematic diagram of construction of
pDM628. B and C. The 293T cells were co-transfected with pDM628, pRL-TK (as a transfection normalization reporter), pcDNA3.1-Rev and pcDNA3.1-
DDX5-HA (or pcDNA3.1). The cells were lysed at 48 h p.t. for luciferase activity assay. D. pDM628, pRL-TK, pcDNA3.1-Rev and DDX5-siRNA were
transfected into 293T cells. After 48 h, cells were lysed for luciferase activity assay. Data in B, C and D represent mean 6S.D. (error bars).
doi:10.1371/journal.pone.0065040.g002
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with SDS-PAGE and subsequently immunoblotted. As shown in
Fig. 5B (left), DDX5 was specifically co-immunoprecipitated with
Rev but not with the control GFP. Because RNA helicases usually
interact with RNA and play a role in several RNA-related
biological processes [12,33,34], the immunoprecipitated samples
were then treated with RNase mixture. After RNase treatment,
the interaction between DDX5 and Rev was reduced significantly
and only a few DDX5 proteins were detected (Fig. 5C, top panel),
indicating that the binding of DDX5 and Rev is largely dependent
on some cellular RNAs. As HIV-1 transcript is also RNA, we
hypothesized that the addition of HIV-1 transcript might affect the
binding of Rev to DDX5. To confirm this speculation, 2 mg
pMDLg/RRE (pcDNA3.1 as a control) and 4 mg pcDNA3.1-Rev-
HA (pcDNA3.1-GFP-HA as a control) were co-transfected into
HeLa cells and then these cell samples were immunoprecipitated
with anti-HA antibody and analyzed by Western blotting (Fig. 5C,
bottom panel). The data showed that HIV-1 transcript generated
from pMDLg/RRE can enhance the interaction between Rev and
DDX5.
As the DEAD-box motif plays an important role in the function
of the DEAD-box RNA helicase family, the interaction between
DDX5 with the DEAD-box mutant and Rev was evaluated. The
pcDNA3.1-DDX5 mutant-FLAG or pcDNA3.1-DDX5 mutant-
HA was generated by replacing the DEAD-box motif in DDX5
with 4 alanine amino acids. HeLa cells were then co-transfected
with pcDNA3.1-Rev-HA and pcDNA3.1-DDX5 mutant-FLAG.
The immunoprecipitated samples were analyzed with SDS-PAGE
and immunoblotted after immunoprecipitation with anti-HA
antibody. Compared with wild-type DDX5, the interaction
between the DDX5-DEAD-box mutant and Rev was reduced
significantly (Fig. 5D). After co-transfection with Rev, the
localization pattern of DDX5 mutant was also detected. However,
DDX5-DEAD-box mutant showed a diffuse nuclear staining but is
largely excluded from the nucleoli (Fig. 5E). This mislocalization of
DDX5 mutant maybe affect its ability to interact with Rev.
Furthermore, the DDX5-DEAD-box mutant lacked the ability to
enhance the expression of the Rev-dependent reporter in pDM628
(Fig. 5F). These results indicated that the DEAD-box motif of
DDX5 is very important for the binding of DDX5 and Rev, and
that it is also required for DDX5 to enhance Rev function.
Discussion
Genome-wide screenings for HIV-1-associated cellular factors
have recently been performed by several groups. Consolidating
these data, more than 300 HIV-1-associated host factors have
been found [5,17,18,19,20,21,22]. Bushman et al analyzed the full
set of proteins implicated in HIV-1 infection and classified these
Figure 3. DDX5 modulates Rev/RRE- but not CTE-dependent reporter gene expression. A. Schematic maps of pMDLg/CTE and pMDLg/
RRE. B. The 293T cells were co-transfected with pMDLg/RRE (or pMDLg/CTE), pcDNA3.1-Rev and pcDNA3.1-DDX5-HA (pcDNA3.1 as a control). C. The
293T cells were co-transfected with pMDLg/RRE (or pMDLg/CTE) and pcDNA3.1-Rev in the presence of DDX5-siRNA (GFP-siRNA as a control). B and C.
The supernatants were collected for assay of HIV-1 p24 ELISA at 48 h p.t. Western blotting analysis was performed to confirm p55 Gag expression
with anti-p24 antibody. The results are mean values with 6S.D. from triplicate samples.
doi:10.1371/journal.pone.0065040.g003
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factors into 11 clusters according to their putative functions. Of
these clusters, the function of certain proteins in the eleventh
cluster remains unknown, although they appear to be involved in a
Rev-associated complex, suggesting specific link to HIV-1
replication [18]. DDX5 is among these cellular factors and our
present works have demonstrated that DDX5 can enhance HIV-1
replication by interacting with Rev and positively affect its
function.
DDX5, also known as p68 RNA helicase, is a member of the
eleventh cluster and belongs to the DEAD-box RNA helicase
family [18]. As an early example of cellular RNA helicases, DDX5
exhibits many functions, as do other RNA helicases; e.g., the
ATPase and RNA-unwinding activities of DDX5 have been
previously identified [36,37,38]. DDX5 also plays a role in DNA
methylation/demethylation, apoptosis, cell proliferation and early
organ maturation [39,40,41]. In addition, several groups have
suggested that DDX5 may be correlated with transcriptional
regulation of a number of genes [39,42,43,44,45,46]. Although
DDX5, DDX1 and DDX3 belong to the DEAD-box RNA
helicase family, DDX5 is quite different from DDX1 and DDX3
in either structure or function. For instance, DDX5 does not have
a SPRY domain as DDX1 has, and the modification of its amino
acids is much more significant than that of DDX1. For gene
transcriptional regulation, DDX5 is a co-regulator of some
transcription factors including ESR1, p53, MYOD1 and RUNX2,
but this effect is not dependent on its ATPase/helicase activity
[39,43,45,47,48]. Conversely, DDX1 acts as a co-activator to
enhance NF-kB-mediated transcriptional activation and the
expression of cyclin CCND2 [49,50]. However, DDX3 enhances
the expression of the CDKN1A/WAF1 promoter in a SP1-
dependent manner and down-regulates the expression of the E-
cadherin promoter [51,52,53]. For pre-mRNA processing, DDX5
is directly involved in the alternative regulation of some pre-
mRNA splicing [54]; DDX1 may also be involved in 39-end
cleavage and polyadenylation of pre-mRNA [55], whereas DDX3
does not seem to be directly involved in splicing and rather
associates with spliced mRNAs in an exon junction complex-
dependent manner [56]. For regulation of apoptosis, DDX5 plays
a role in the p53/TP53-dependent apoptotic pathway [39,57];
DDX3 acts as an anti-apoptotic protein by association with GSK3
and cIAP-1 in a death-antagonizing signaling complex at death
receptors to inhibit apoptotic signaling [58]. These significant
functional differences show the diversity of the DEAD-box RNA
helicase family and indicate that DDX5 has its own unique
structure and function.
As we report here, DDX5 is shown to possess a novel function,
acting as a co-factor of Rev; and is important for Rev/RRE-
mediated HIV-1 mRNAs export. Our results showed that DDX5
overexpression enhanced HIV-1 replication significantly (Fig. 1A,
E). To confirm this phenotype, a dose-dependence experiment was
performed. We found that DDX5 enhanced HIV-1 p24 expres-
sion in a dose-dependent manner (Fig. 1C, D). Conversely, the
depletion of DDX5 by DDX5-specific siRNA resulted in a
significant inhibition of p24 production (Fig. 1F and Fig. S1A).
These results are consistent with our own work (Fig. A–E) and
previous studies which showed that the depletion of DDX1 or
DDX3 reduced p24 expression significantly [9,10]. Since DDX1
and DDX3 are already known to play a role in HIV-1 replication,
a substitution experiment was performed to detect the particular
importance of DDX5. The data in Fig. S1B showed that the
expression of DDX1 or DDX3 in the presence of DDX5
knockdown only partially recued the function of DDX5, indicating
that DDX5 has its unique function in HIV-1 replication.
However, our results disagree with the results in a recent report
that DDX5 silencing strongly increased p24 release [59]. The
authors of this report argued that DDX5 and DDX17 could form
homodimers or heterodimers in cells [60], the silencing of DDX5
could increase the concentration of the DDX17 homodimers so as
to enhance HIV-1 production. However, there is no evidence
supporting their hypothesis. We used the same DDX5-specific
siRNA as they used in their study (data not shown) and another
DDX5-specific siRNA (Fig. 1F) to repeat this experiment.
However, both of the results showed that the depletion of
DDX5 reduced rather than increased p24 expression significantly.
A previous report has suggested that DDX5 and some cellular
proteins are possibly involved in Rev-related function [18]. We
therefore examined the relationship between DDX5 and the Rev-
dependent reporter plasmid (pDM628, Fig. 2A) [9]. In line with
the functions of DDX1 and DDX3, we found that DDX5 is
required for the efficient function of Rev in a dose-dependent
manner (Fig. 2B, C) and this phenotype is also recapitulated in the
DDX5-silencing experiment (Fig. 2D). We also found that DDX5
regulates Rev/RRE- but not CTE-dependent reporter gene
expression by using pMDLg/RRE and pMDLg/CTE reporter
plasmids (Fig. 3). Zolotukhin et al showed that CTE-mediated
expression of Gag is Rev independent [7]. In contrast to DDX5,
another RNA helicase, RNA helicase A (RHA), plays a role in the
nuclear export of CTE-containing RNAs [61]. RHA interacts with
some shuttling proteins (TAP or a novel A kinase-anchoring
protein HAP95) and displays its function by direct binding to
CTE-containing RNA [62,63,64]. As neither the RHA/HAP95
nor the RHA/TAP complex affects the gene expression of Rev-
RRE-dependent reporter [62,64], and DDX5 does not affect the
export of CTE-containing RNA, RHA and DDX5 belong to
different RNA transport complexes and the nuclear export of
CTE-containing RNAs or RRE-containing RNAs needs distinct
co-factors.
As the main function of Rev is to bind with unspliced and
partially spliced HIV-1 transcripts and shuttle them from the
nucleus to the cytoplasm, DDX5 might participate in this activity
as a co-factor binding with RNA and affecting either splicing or
export of HIV-1 transcripts. Our results indicate that DDX5
augments the cytoplasmic accumulation (Fig. 4C) and cytoplasm/
nuclear ratios of Rev/RRE-dependent mRNAs (Fig. 4B), but does
Figure 4. DDX5 enhanced the export of Rev/RRE-dependent mRNAs. A. Top, schematics of three size classes of HIV-1 RNAs. Bottom, the
effect of DDX5 overexpression on HIV-1 mRNA splicing. The 293T cells were co-transfected with pNL4-3DEnv-GFP and pcDNA3.1-DDX5-HA (or
pcDNA3.1), respectively. Total RNA was extracted from transfected cells and analyzed with qRT-PCR using primers specific to rev mRNA, tat mRNA or
gag-pol mRNA. B. pDM628, pcDNA3.1-Rev and pcDNA3.1-DDX5-HA (pcDNA3.1 as a control) were transfected into 293T cells. Cells were collected for
fractionation of cytoplasmic or nuclear components and then RNA extraction. Real-time RT-PCR was performed using primers specific to pDM628
mRNA. C and D. The 293T cells were co-transfected with pMDLg/RRE (or pMDLg/CTE), pcDNA3.1-Rev and pcDNA3.1-DDX5-HA (pcDNA3.1 as a
control). E and F. The 293T cells were co-transfected with pMDLg/RRE (or pMDLg/CTE), pcDNA3.1-Rev (pcDNA3.1 as a control) and DDX5-siRNA (GFP-
siRNA as a control). C, D, E and F. Cytoplasmic and whole-cell RNAs isolated from 293T cells at 48 h p.t. were analyzed using real-time RT-PCR. B, C,
D, E and F. Human GAPDH and/or b-actin mRNA was measured as an endogenous control. The Western blotting images assess the purity of nuclear
extracts (NE) and cytoplasmic extracts (CE): TBP measured as a NE control and b-actin measured as a CE control. Data in A, B, C, D, E and F. represent
mean 6 S.D. (error bars).
doi:10.1371/journal.pone.0065040.g004
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Figure 5. The interaction between DDX5 and Rev is largely dependent on RNA. A and E. Confocal images of transfected HeLa cells. A. HeLa
cells were co-transfected with Rev-GFP- and DDX5-HA-expressing plasmids. E. HeLa cells were co-transfected with Rev-GFP- and DDX5 mutant-HA-
expressing plasmids. A and E. At 36 h p.t., the transfected cells were observed for fluorescence by confocal laser scanning microscopy. B and C (Top
panel). The transfected HeLa cells expressing Rev-HA or GFP-HA were lysed and immunoprecipitated with anti-HA agarose beads. B. Anti-HA
immunoprecipitates were analyzed by Western blotting with anti-HA or anti-DDX5 antibody. C (Top panel). The immunoprecipitates were treated
with or without RNase mixture. Samples were analyzed by immunoblotting using anti-HA or anti-DDX5 antibody. C (bottom panel). HeLa cells were
co-transfected with pcDNA3.1-Rev-HA (pcDNA3.1-GFP-HA as a control) and pMDLg/RRE (pcDNA.3.1 as a control) were lysed and immunoprecipitated
with anti-HA agarose beads. Anti-HA immunoprecipitates were analyzed by Western blotting with anti-HA or anti-DDX5 antibody. D. HeLa cells were
co-transfected with pcDNA3.1-Rev-HA and pcDNA3.1-DDX5 mutant-FLAG (pcDNA3.1-GFP-HA and pcDNA3.1-DDX5-FLAG as controls). After
immunoprecipitation with anti-HA antibody, the immunoprecipitated samples were analyzed with SDS-PAGE and immunoblotting with anti-HA or
anti-FLAG antibody. F. The 293T cells were co-transfected with pDM628, pRL-TK (as a transfection normalization reporter), pcDNA3.1-Rev and
differing amounts of pcDNA3.1-DDX5 mutant-FLAG (or pcDNA3.1). The cells were lysed at 48 h p.t. for luciferase activity assay.
doi:10.1371/journal.pone.0065040.g005
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not affect the splicing of HIV-1 RNAs (Fig. 4A and Fig. S3). To
elucidate the mechanism underlying the phenotypes, we further
detected the interaction between DDX5 and Rev by confocal
microscopy and co-immunoprecipitation analysis. DDX5 was
mainly found in the nucleus of transfected cells (Fig. 5A). This is
consistent with a previous study that described DDX5 as a
nuclear-cytoplasmic shuttling protein with a much longer
residence time in the nucleus [24]. As Rev is a nuclear-cytoplasmic
shuttling protein and some Rev proteins were also detected in the
nucleus (Fig. 5A) and partially co-localized with DDX5 (Fig. 5A),
our findings suggest that DDX5 partially co-localizes with Rev in
the nucleus of human cells. Alternatively, our co-immunoprecip-
itation analysis further confirmed that DDX5 binds to Rev in an
RNA-dependent manner and the interaction between DDX5 and
Rev is promoted by some cellular RNAs or HIV-1 transcript
(Fig. 5B, C). This is in partial agreement with previous reports
regarding the interaction between DDX1 or DDX3 with Rev
[9,10]. As the DEAD-box motif is required for the function of
DEAD-box RNA helicases, the localization pattern of DDX5-
DEAD-box mutant and the binding of the DDX5 mutant and Rev
were also examined. The co-immunoprecipitation and confocal
imaging analysis indicated that the DEAD-box motif plays an
important role in the interaction between DDX5 and Rev (Fig. 5D
and E), and that it is also required for DDX5 to enhance Rev
function (Fig. 5F).
Collectively, our analyses have identified that DDX5 functions
as a new co-factor of Rev, facilitating Rev/RRE-mediated nuclear
export of HIV-1 transcripts and enhancing the replication of HIV-
1. Our data reveals a new potential molecular target for anti-HIV-
1 therapeutics. As there are several active drug-research programs
that target virus-encoded helicases [65,66], it remains to be
determined whether small molecular inhibitors upon the interac-
tion between DDX5 and Rev can be found.
Supporting Information
Figure S1 DDX5 is important for HIV-1 replication. A.
The effect of DDX5 knockdown on HIV-1 p24 production. Top,
the supernatants from 293T cells transfected with pNL4-3DEnv-
GFP in the presence of DDX5-siRNA (GFP-siRNA as a control)
were collected at 48 h p.t. and analyzed with p24 ELISA kit.
Bottom, the effect of DDX5-siRNA in 293T cells was detected by
Western blotting. B. Substitution experiment by DDX1 or DDX3.
The 293T cells were transfected with pNL4-3DEnv-GFP and
DDX5-siRNA (GFP-siRNA as a control). Then, DDX1- or
DDX3-expressing plasmid was transfected into these cells. The
culture supernatants were collected at 48 h p.t. for assay of p24
ELISA. Data in A and B represent mean 6S.D. (error bars).
(TIF)
Figure S2 The effect of DDX5 on the transcription of
reporter genes. A and B. The 293T cells were co-transfected
with pDM628 (A) or pRL-TK (B) and differing amounts of
pcDNA3.1-DDX5-HA (pcDNA3.1 as a control), respectively.
Total RNA was extracted from the transfected cells and analyzed
with qRT-PCR using primers specific to firefly luciferase mRNA or
renilla luciferase mRNA. Data in A and B. represent mean 6 S.D.
(error bars).
(TIF)
Figure S3 The effect of DDX5 knockdown on HIV-1
mRNA splicing. The 293T cells were co-transfected with pNL4-
3DEnv-GFP and DDX5-siRNA (GFP-siRNA as a control),
respectively. Total RNA was extracted from the transfected cells
and analyzed with qRT-PCR using primers specific to rev mRNA,
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